Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 310

Similar articles for PubMed (Select 12783850)

1.

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A, Robinson JC, Pradier L, Ruberg M, Mirande M, Hirsch E, Rooney T, Fournier A, Brice A.

Hum Mol Genet. 2003 Jun 15;12(12):1427-37.

2.

Altered protein expression pattern in skin fibroblasts from parkin-mutant early-onset Parkinson's disease patients.

Lippolis R, Siciliano RA, Pacelli C, Ferretta A, Mazzeo MF, Scacco S, Papa F, Gaballo A, Dell'Aquila C, De Mari M, Papa S, Cocco T.

Biochim Biophys Acta. 2015 Jun 19. pii: S0925-4439(15)00181-7. doi: 10.1016/j.bbadis.2015.06.015. [Epub ahead of print]

PMID:
26096686
3.

Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.

Im E, Chung KC.

J Neurochem. 2015 May 12. doi: 10.1111/jnc.13164. [Epub ahead of print]

PMID:
25963095
4.

Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Fiesel FC, Caulfield TR, Moussaud-Lamodière EL, Ogaki K, Dourado DF, Flores SC, Ross OA, Springer W.

Hum Mutat. 2015 May 5. doi: 10.1002/humu.22808. [Epub ahead of print]

PMID:
25939424
5.

Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.

Ozgul S, Kasap M, Akpinar G, Kanli A, Güzel N, Karaosmanoglu K, Baykal AT, Iseri P.

Neurochem Int. 2015 Jun-Jul;85-86:1-13. doi: 10.1016/j.neuint.2015.03.007. Epub 2015 Apr 9.

PMID:
25865804
6.

Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Chakraborty S, Chen P, Bornhorst J, Schwerdtle T, Schumacher F, Kleuser B, Bowman AB, Aschner M.

Metallomics. 2015 May 13;7(5):847-56. doi: 10.1039/c5mt00052a. Epub 2015 Mar 13.

PMID:
25769119
7.

Pathologic and therapeutic implications for the cell biology of parkin.

Charan RA, LaVoie MJ.

Mol Cell Neurosci. 2015 May;66(Pt A):62-71. doi: 10.1016/j.mcn.2015.02.008. Epub 2015 Feb 17. Review.

PMID:
25697646
8.

Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter.

Hasson SA, Fogel AI, Wang C, MacArthur R, Guha R, Heman-Ackah S, Martin S, Youle RJ, Inglese J.

ACS Chem Biol. 2015 May 15;10(5):1188-97. doi: 10.1021/cb5010417. Epub 2015 Feb 26.

PMID:
25689131
9.

STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.

Kurup PK, Xu J, Videira RA, Ononenyi C, Baltazar G, Lombroso PJ, Nairn AC.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1202-7. doi: 10.1073/pnas.1417423112. Epub 2015 Jan 12.

PMID:
25583483
10.

Cytoskeletal Alterations and Biomechanical Properties of parkin-Mutant Human Primary Fibroblasts.

Vergara D, Ferraro MM, Cascione M, Del Mercato LL, Leporatti S, Ferretta A, Tanzarella P, Pacelli C, Santino A, Maffia M, Cocco T, Rinaldi R, Gaballo A.

Cell Biochem Biophys. 2014 Nov 16. [Epub ahead of print]

PMID:
25399302
11.

Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons.

Ren Y, Jiang H, Hu Z, Fan K, Wang J, Janoschka S, Wang X, Ge S, Feng J.

Stem Cells. 2015 Jan;33(1):68-78. doi: 10.1002/stem.1854.

12.

Parkin regulates kainate receptors by interacting with the GluK2 subunit.

Maraschi A, Ciammola A, Folci A, Sassone F, Ronzitti G, Cappelletti G, Silani V, Sato S, Hattori N, Mazzanti M, Chieregatti E, Mulle C, Passafaro M, Sassone J.

Nat Commun. 2014 Oct 15;5:5182. doi: 10.1038/ncomms6182.

13.

Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.

Scuderi S, La Cognata V, Drago F, Cavallaro S, D'Agata V.

Biomed Res Int. 2014;2014:690796. doi: 10.1155/2014/690796. Epub 2014 Jul 16.

14.

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.

Romaní-Aumedes J, Canal M, Martín-Flores N, Sun X, Pérez-Fernández V, Wewering S, Fernández-Santiago R, Ezquerra M, Pont-Sunyer C, Lafuente A, Alberch J, Luebbert H, Tolosa E, Levy OA, Greene LA, Malagelada C.

Cell Death Dis. 2014 Aug 7;5:e1364. doi: 10.1038/cddis.2014.333.

15.

Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals.

Duong T, Kim J, Ruley HE, Jo D.

PLoS One. 2014 Jul 14;9(7):e102517. doi: 10.1371/journal.pone.0102517. eCollection 2014.

16.

Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.

Bendikov-Bar I, Rapaport D, Larisch S, Horowitz M.

Orphanet J Rare Dis. 2014 Jun 16;9:86. doi: 10.1186/1750-1172-9-86.

17.

Switching on ubiquitylation by phosphorylating a ubiquitous activator.

Shaw GS.

Biochem J. 2014 Jun 15;460(3):e1-3. doi: 10.1042/BJ20140459.

PMID:
24870025
18.

Aberrant autophagy and parkinsonism: does correction rescue from disease progression?

Mishra AK, Ur Rasheed MS, Shukla S, Tripathi MK, Dixit A, Singh MP.

Mol Neurobiol. 2015 Jun;51(3):893-908. doi: 10.1007/s12035-014-8744-3. Epub 2014 May 16.

PMID:
24833602
19.

Functional Role of Parkin against Oxidative Stress in Neural Cells.

Hwang M, Lee JM, Kim Y, Geum D.

Endocrinol Metab (Seoul). 2014 Mar;29(1):62-9. doi: 10.3803/EnM.2014.29.1.62. Epub 2014 Mar 14.

20.

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.

Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin UM, Lees A, Troncoso JC, Lewis PA, Bandopadhyay R, Schneider BL, Moore DJ.

Hum Mol Genet. 2014 Sep 1;23(17):4621-38. doi: 10.1093/hmg/ddu178. Epub 2014 Apr 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk